(Q40473787)

20 September 2017

title

Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. (English)

1 reference

Rift Valley fever phlebovirus

20 September 2017

main subject

0 references

vaccine

0 references

author name string

Wallace DB

1

1 reference

20 September 2017

Ellis CE

2

1 reference

20 September 2017

Espach A

3

1 reference

20 September 2017

Smith SJ

4

1 reference

20 September 2017

Greyling RR

5

1 reference

20 September 2017

Viljoen GJ

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

5 July 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

49-50

1 reference

20 September 2017

page(s)

7181-7189

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

20 September 2017

1 reference

An epizootic of Rift Valley fever in Egypt in 1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Observations on the epidemiology of lumpy skin disease in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

A single vaccine for the control of capripox infection in sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

The characterization of African strains of capripoxvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Relationships of capripox viruses found in Kenya with two Middle Eastern strains and some orthopox viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

One-step procedure for screening recombinant plasmids by size.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

The pMTL nic- cloning vectors. I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Evidence of sheep pox in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Clinical and antigenic relationship between isolates of sheep and goat pox viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.041

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.06.041

1 reference

20 September 2017

1 reference